
Symbol Search

or enter GC* - Gold Futures

Quotes and Charts

YOU ARE HERE: Stocks » Quotes and Charts » News Headlines

Alexion Pharmaceuticals (ALXN)

99.17-0.71 (-0.71%) 4:17P EDT (NASDAQ) - [After Hours: 99.17unch (unch) 4:20P EDT]

Price Quote as of Friday, May 24th, 2013

Latest Alexion Pharmaceuticals (ALXN) Headlines

Positive Data on Bayer Candidate - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Thu May 23, 9:05PM CDT

Bayer announced positive results from an interim analysis of the phase III PATENT-2 trial on its pipeline candidate riociguat. (full story)

Alkermes Reports Earnings for Q4 - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Thu May 23, 6:07PM CDT

Alkermes plc's fourth quarter of fiscal 2013 adjusted earnings of 21 cents per share compared favorably to the year-ago loss of 13 cents per share. (full story)

Alexion to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Business Wire - Thu May 23, 9:00AM CDT

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Deutsche Bank 38th Annual dbAccess Health Care Conference in Boston at 3:30 p.m. Eastern time on Thursday, May 30, 2013. (full story)

Bayer Files Riociguat in Japan - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Tue May 21, 11:20PM CDT

Bayer submitted a regulatory application for its CTEPH candidate, riociguat, in Japan. (full story)

Yet Another Acquisition for Bayer - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Tue May 21, 2:50PM CDT

Bayer inked a deal to acquire all shares of Germany-based Steigerwald Arzneimittelwerk. (full story)

Biogen's Hemophilia BLA Accepted - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Mon May 20, 3:10PM CDT

Biogen's hemophilia B candidate, Alprolix, is also under FDA review. (full story)

Critical Alerts For Wells Fargo, Alexion Pharmaceuticals, Cigna, Deckers Outdoor, and Yelp Released By InvestorsObserver

PR Newswire - Mon May 20, 8:31AM CDT

InvestorsObserver issues critical PriceWatch Alerts for WFC, ALXN, CI, DECK, and YELP. (full story)

Bayer's Xofigo Cleared in the US - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Thu May 16, 5:45PM CDT

Bayer's received encouraging news as the FDA approved its oncology drug Xofigo (full story)

SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 1.65% Gain

Comtex SmarTrend(R) - Thu May 09, 4:01PM CDT

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $96.70 to a high of $99.84. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $98.64 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Alexion to Present at the BofA Merrill Lynch 2013 Healthcare Conference

Business Wire - Wed May 08, 9:00AM CDT

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the BofA Merrill Lynch 2013 Healthcare Conference in Las Vegas at 8:00 a.m. Pacific time (11:00 a.m. Eastern time) on Wednesday, May 15, 2013. (full story)